Planetary Technologies Secures $11.35 Million USD Series A Funding for OceanBased Climate Solutions
| | | |

Planetary Technologies Secures $11.35 Million USD Series A Funding for OceanBased Climate Solutions

Planetary Technologies, a leader in oceanbased climate solutions, has successfully completed its Series A funding round, raising $11.35 million USD. The company focuses on utilizing ocean alkalinity enhancement (OAE) to remove carbon dioxide from the atmosphere, ultimately enhancing the oceans natural ability to fight climate change through carbon removal and storage. This innovative approach restores…

Rivermark Medical Secures $30 Million Series C Funding for BPH Treatment Technology
| | | |

Rivermark Medical Secures $30 Million Series C Funding for BPH Treatment Technology

Rivermark Medical, a leader in minimally invasive solutions for Benign Prostatic Hyperplasia (BPH), has closed a $30 million Series C financing round. The funding will advance the clinical development of Rivermarks flagship product, the FloStent™ System, designed to restore urinary function for BPH patients. Widespread financial support from investors like American Century Investments (ACI), Venture…

Lesaffre Acquires Altar, French Startup Specializing in Adaptive Laboratory Evolution
| | |

Lesaffre Acquires Altar, French Startup Specializing in Adaptive Laboratory Evolution

Lesaffre, a prominent global player in fermentation and microorganisms, has announced the acquisition of Altar, a French startup specializing in Adaptive Laboratory Evolution (ALE). Altar, founded in 2017, has developed cuttingedge technology for the continuous cultivation of microorganisms under controlled conditions to select strains with specific properties. This acquisition of Altar complements Lesaffres existing knowhow…

TEDCO Announces 10th Annual Entrepreneur Expo in Baltimore
| | | | | |

TEDCO Announces 10th Annual Entrepreneur Expo in Baltimore

TEDCO, the Maryland Technology Development Corporation, is thrilled to announce the 10th Entrepreneur Expo scheduled for December 4, 2024, at the Renaissance Harborplace Baltimore Hotel. This event serves as a key gathering for Marylands entrepreneurial community, showcasing resources and providing valuable networking opportunities. The Expo caters to a diverse audience, including entrepreneurs, investors, policymakers, and…

XP Health Secures $33.2 Million Series B Funding for DigitalFirst Vision Care Platform
| | | | |

XP Health Secures $33.2 Million Series B Funding for DigitalFirst Vision Care Platform

XP Health, a company dedicated to modernizing vision care with a digitalfirst vision care platform, has raised a total of more than $55 million in funding. The latest round of $33.2 million in Series B funding was led by global fintech VC firm QED Investors. Other prominent investors in this round include Canvas Ventures, American…

PsychoGenics Awarded Fast Track SBIR Grant for AIEnabled Drug Discovery
| | | |

PsychoGenics Awarded Fast Track SBIR Grant for AIEnabled Drug Discovery

PsychoGenics, a leader in AIenabled phenotypic drug discovery, has been awarded a Fast Track Small Business Innovation Research (SBIR) grant by NIMH, worth up to $3 million over four years. The grant will support PsychoGenics in utilizing eCube®, its proprietary AIenabled EEG platform, to identify novel applications for existing drugs targeting rare diseases. With approximately…

Grünenthal Acquires Valinor Pharma in AllStock Deal
| | |

Grünenthal Acquires Valinor Pharma in AllStock Deal

German pharmaceutical company Grünenthal has acquired Valinor Pharma in an allstock deal worth approximately $250 million. Valinor Pharma, known for its ownership of Movantik® (naloxegol), had shown significant growth under the leadership of CEO Todd N. Smith and President Ben Bove. The acquisition marks a strategic move by Grünenthal to expand its pharmaceutical portfolio and…

Adona Medical Secures $33.5 Million in Series C Funding for Heart Failure Solution
| | | | |

Adona Medical Secures $33.5 Million in Series C Funding for Heart Failure Solution

Adona Medical, a Shifamed portfolio company specializing in advanced solutions for heart failure, has successfully secured $33.5 million in Series C financing. The funding will support the next stage of product development and early clinical experience for their novel interatrial shunt and remote monitoring solution designed for patients with heart failure. The financing round was…

Active Membranes Closes Seed Funding Round for Revolutionary Desalination Technology
| | | |

Active Membranes Closes Seed Funding Round for Revolutionary Desalination Technology

Active Membranes, a developer of electricallyconducting membranes for desalination, has successfully closed its initial round of Seed Funding. The funding will be used to further develop their gamechanging desalination technology, facilitate corporate growth, scaleup technology, and advance commercialization. Additionally, the investment will support extended field pilot tests cofunded by various US federal and state government…

Waypoint Bio Secures $14.5 Million in Seed Funding for Novel Cell Therapy Platform
| | | | |

Waypoint Bio Secures $14.5 Million in Seed Funding for Novel Cell Therapy Platform

Waypoint Bio, a biotechnology company specializing in cell therapies for solid tumors, has announced a successful seed funding round of $14.5 million. The funding will be utilized to advance their innovative platform that combines spatial biology with pooled screening technology to develop novel cell therapies for challenging diseases like pancreatic cancer. The funding round was…